Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03612596 · ClinicalTrials.gov registry record · NA

Narrative Visualization for Breast Cancer Survivors' Physical Activity

A NA study of Breast Cancer, sponsored by The University of Texas Medical Branch, Galveston.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT03612596 is a NA study of Breast Cancer that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 40 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03612596, a NA study of Breast Cancer, has completed, sponsored by The University of Texas Medical Branch, Galveston.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study tests the feasibility and acceptability of a physical activity intervention that combines use of a wearable activity monitor with a scrapbook. Half of the participants will receive this enhanced intervention, while the other half will receive a wearable activity monitor with a standard step log.

Conditions Studied

Interventions

  • BEHAVIORAL Standard self-regulation
  • BEHAVIORAL Narrative visualization

Study Locations (1)

Texas

  • The University of Texas Medical Branch - Galveston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2018-09-01
Est. Completion 2022-03-31
Phase NA

What the Registry Record Tells You About NCT03612596

The ClinicalTrials.gov registry entry for NCT03612596 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Standard self-regulation is the first listed.

NCT03612596 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03612596 about?

NCT03612596 is a clinical study titled "Narrative Visualization for Breast Cancer Survivors' Physical Activity". This study tests the feasibility and acceptability of a physical activity intervention that combines use of a wearable activity monitor with a scrapbook. Half of the participants will receive this enhanced intervention, while the other half will receive a wearable activity monitor with a standard st...

What is the current status of trial NCT03612596?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2018-09-01. Estimated completion is 2022-03-31.

What conditions does trial NCT03612596 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT03612596?

The interventions under investigation include: Standard self-regulation (BEHAVIORAL), Narrative visualization (BEHAVIORAL).

Who is sponsoring clinical trial NCT03612596?

This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03612596 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.